Related Experiment Videos
A new antiinflammatory agent (EGIS-5645) without gastrointestinal side-effect
G Gigler1, E Kiszelly, P Tömpe
1EGIS Pharmaceuticals, Budapest, Hungary.
Agents and Actions. Supplements
|January 1, 1991
Abstract:
The compound EGIS-5645 is a potent antipyretic agent possessing analgesic and antiinflammatory properties. The drug is active in antiinflammatory models such as carrageenin oedema and adjuvant arthritis. EGIS-5645 shows practically no gastro-ulcerogenic effect. The molecule does not inhibit either prostaglandin biosynthesis or soybean lipoxygenase enzyme activity.